Navigation Links
AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance

BOSTON, May 14, 2013 /PRNewswire/ -- On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape.

Among the clinical trial leaders in attendance will be AG Mednet CEO Abraham Gutman who will moderate a special program about successful site leadership and disruptive technologies transforming investigator sites and challenging old assumptions among global networks.

Gutman, recently recognized by CenterWatch as one of 20 innovators changing the face of the clinical trial industry, is responsible for leading AG Mednet and its breakthrough technology that improves the quality of clinical trials by eliminating preventable and costly human errors.

For more information about AG Mednet or to schedule a conversation with Abraham Gutman about the role of disruptive technologies at clinical trial investigative sites around the world, please email

For more information about the Inaugural Forum on Optimizing Clinical Research Performance, please visit

About AG Mednet

AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 17,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world's top 20 pharmaceutical, biotech and medical device companies.

Media Contact: 
Dawn Sullivan or Molly Delaney 
HB Agency 

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
2. AG Mednet and Japans Biovisiq Bring Zero-Delay Clinical Trial Solutions to Asian Pharmaceutical Market
3. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
4. AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data
5. MedNet Solutions To Sponsor And Participate In The 2012 SCDM Annual Conference
6. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
7. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
8. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
(Date:11/26/2015)... , 26 november 2015 AAIPharma ... de geplande investering aan van ten minste ... laboratoria en het mondiale hoofdkantoor in ... zal resulteren in extra kantoorruimte en extra ... de groeiende behoeften van de farmaceutische en ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was ... inventor from Hillside, N.J. "Many people catch diseases simply from sitting on such ... always be protected from germs." , He developed the patent-pending QUDRATECS to eliminate ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 27, 2015 , ... The moment you stop improving is ... fulfilling the needs of advisers and clients but going above and beyond to ... customer service. However, there's always room for improvement, which is why the entire ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Dr. ... Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., ... observed that both STEMI and Sepsis conditions present in similar ways and require time-critical ...
Breaking Medicine News(10 mins):